News
Tobacco Control Research Groups awarded by the WHO
The Tobacco Control Research Group has received one of the World No Tobacco Day 2021 Awards from the World Health Organization for their work in the field of tobacco control.
Starts the campaign “Let’s push tobacco away”
This campaign, launched by the Catalan Network of Smoke-Free Hospitals, wants to move away tobacco from the hospital environment.
Fernando Fernández Aranda, the new Scientific Director of IDIBELL
Fernando Fernández-Aranda takes over from Josep Manuel Menchón as Scientific Director. This nomination will allow continuing the IDIBELL’s promotion as a reference center in biomedical research.
IDIBELL researchers identify a brain region that predicts the evolution of apathy in Huntington’s patients
The atrophy of a specific region of the cerebral cortex is related to the appearance of apathy in Huntington’s patients, a neurodegenerative disease that affects motor and cognitive function. This is the conclusion of a study of the Bellvitge Biomedical Research Institute (IDIBELL) published in the Movement Disorders journal.
A connection between senescence and stem cells caused by a breast cancer-initiating protein
Hyperactivation of the RANK pathway plays a double function in breast cells: in the early stages of cancer, it activates senescence, which has a protective effect and delays the appearance of tumours
May 12 – International Nursing Day
The date of the election to celebrate this anniversary coincides with the birth of nurse Florence Nightingale, a pioneer of modern nursing
Researchers identify a possible therapy against Rendu-Osler disease
Research It is a rare disease that causes malformations in blood vessels. The study has discovered the implication of a protein in the development of the pathology.
Isabel Fabregat receives a grant from the Ramón Areces Foundation to study liver fibrosis
The Ramón Areces Foundation has awarded Grants for Research in Life Sciences and Matter corresponding to its 20th edition. In intercellular dialogue and interactome area, Dr. Isabel Fabregat, head of the research group “TGF-beta and cancer” at IDIBELL, in collaboration with Drs. Aránzazu Sánchez and Blanca Herrera from the Complutense University of Madrid, have received one of the grants.
60% of Covid-19 patients develop neurological symptoms
60% of Covid-19 inpatients develop neurological symptoms and 12% of post-Covid patients have neurological sequelae.